rs201309183
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_021098.3(CACNA1H):c.4860C>T(p.Asp1620Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000228 in 1,610,388 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_021098.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.4860C>T | p.Asp1620Asp | synonymous_variant | Exon 27 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.4875C>T | p.Asp1625Asp | synonymous_variant | Exon 26 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.4878C>T | p.Asp1626Asp | synonymous_variant | Exon 26 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.4842C>T | p.Asp1614Asp | synonymous_variant | Exon 26 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.4875C>T | p.Asp1625Asp | synonymous_variant | Exon 27 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.4860C>T | p.Asp1620Asp | synonymous_variant | Exon 27 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.4821C>T | p.Asp1607Asp | synonymous_variant | Exon 27 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.4842C>T | p.Asp1614Asp | synonymous_variant | Exon 26 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.4803C>T | p.Asp1601Asp | synonymous_variant | Exon 26 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.4860C>T | p.Asp1620Asp | synonymous_variant | Exon 27 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.4842C>T | p.Asp1614Asp | synonymous_variant | Exon 26 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.4860C>T | p.Asp1620Asp | synonymous_variant | Exon 27 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.4860C>T | p.Asp1620Asp | synonymous_variant | Exon 27 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.4860C>T | p.Asp1620Asp | synonymous_variant | Exon 27 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.4860C>T | non_coding_transcript_exon_variant | Exon 27 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*812C>T | non_coding_transcript_exon_variant | Exon 26 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.4798C>T | non_coding_transcript_exon_variant | Exon 27 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*2711C>T | non_coding_transcript_exon_variant | Exon 27 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4304C>T | non_coding_transcript_exon_variant | Exon 25 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.4842C>T | non_coding_transcript_exon_variant | Exon 26 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.4842C>T | non_coding_transcript_exon_variant | Exon 26 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.4937C>T | non_coding_transcript_exon_variant | Exon 27 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.4860C>T | non_coding_transcript_exon_variant | Exon 27 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.4860C>T | non_coding_transcript_exon_variant | Exon 27 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.4842C>T | non_coding_transcript_exon_variant | Exon 26 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.4860C>T | non_coding_transcript_exon_variant | Exon 27 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.4860C>T | non_coding_transcript_exon_variant | Exon 27 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.4919C>T | non_coding_transcript_exon_variant | Exon 26 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*812C>T | 3_prime_UTR_variant | Exon 26 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000640028.1 | n.*2711C>T | 3_prime_UTR_variant | Exon 27 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4304C>T | 3_prime_UTR_variant | Exon 25 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152168Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000268 AC: 65AN: 242918 AF XY: 0.000235 show subpopulations
GnomAD4 exome AF: 0.000230 AC: 335AN: 1458102Hom.: 2 Cov.: 31 AF XY: 0.000233 AC XY: 169AN XY: 724968 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000210 AC: 32AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
CACNA1H-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at